Share

Comments on:

Drugmaker PTC Therapeutics raises $125M in IPO

Back to the article » |
SOUTH PLAINFIELD, N.J. (AP) — PTC Therapeutics Inc. raised more than $125 million after the drug developer priced an initial public offering of its stock near the top end of the range it expected. The South Plainfield, N.J., company said it expects proceeds of about $114.2 million after deducting underwriting discounts and commissions. The company sold nearly 8.4 million shares at $15 per...

To learn more about commenting on WashingtonExaminer.com and our community guidelines, please see our comments FAQ.